Natalie Compton
Impact in
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies
- Oncology top 10%
- PARP inhibition in cancer therapy
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
Papers in
- Oncology 8
- PARP inhibition in cancer therapy 6
- Lung Cancer Research Studies 2
-
- Lung Cancer Treatments and Mutations 4
- Co-authors
- Kevin J. Harrington (4 shared papers)Nigel Biswas–Baldwin (3 shared papers)Iman El‐Hariry (3 shared papers)Hisham Mehanna (2 shared papers)Éva Remenár (2 shared papers)Mike Lau (2 shared papers)Philippe Legenne (2 shared papers)Martin Housset (1 shared paper)
- Journals
- European Journal of Cancer (3 papers)Annals of Oncology (2 papers)Molecular Cancer Therapeutics (2 papers)British Journal of Cancer (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Natalie Compton
14 papers receiving 427 citations
Peers
Comparison fields: 5 of 65
- Otorhinolaryngology 134
- Oncology 205
- Reproductive Medicine 41
- Pulmonary and Respiratory Medicine 123
- Cancer Research 25
Countries citing papers authored by Natalie Compton
This map shows the geographic impact of Natalie Compton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalie Compton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalie Compton more than expected).
Fields of papers citing papers by Natalie Compton
This network shows the impact of papers produced by Natalie Compton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalie Compton. The network helps show where Natalie Compton may publish in the future.
Co-authors
The 25 scholars most cited alongside Natalie Compton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 89 | |
| 2 | 2012 | 89 | |
| 3 | 2023 | 64 | |
| 4 | 2015 | 46 | |
| 5 | 2016 | 44 | |
| 6 | 2014 | 29 | |
| 7 | 2010 | 22 | |
| 8 | 2010 | 21 | |
| 9 | 2022 | 16 | |
| 10 | 2024 | 7 | |
| 11 | 2024 | 5 | |
| 12 | 2024 | 2 | |
| 13 | 2013 | 1 | |
| 14 | 2025 | 1 |
About Natalie Compton
Natalie Compton is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Otorhinolaryngology, Reproductive Medicine and Molecular Biology, having authored 14 papers that have together received 436 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (6 papers), Lung Cancer Treatments and Mutations (4 papers), Head and Neck Cancer Studies (3 papers), Ovarian cancer diagnosis and treatment (3 papers), Lung Cancer Research Studies (2 papers), Cancer Genomics and Diagnostics (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Mining and Resource Management (1 paper). The work is most often cited by research in Otorhinolaryngology (134 citations), Oncology (205 citations), Reproductive Medicine (41 citations), Pulmonary and Respiratory Medicine (123 citations) and Cancer Research (25 citations). Natalie Compton has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Kevin J. Harrington, Nigel Biswas–Baldwin, Iman El‐Hariry, Hisham Mehanna, Éva Remenár, Mike Lau, Philippe Legenne, Martin Housset, Martin Robinson and Rejnish Kumar. Their work appears in journals such as European Journal of Cancer, Annals of Oncology, Molecular Cancer Therapeutics, British Journal of Cancer and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.